乳酸脱氢酶对评估维吾尔族急性ST段抬高型心肌梗死患者急性左心衰的临床价值

摘要/Abstract

摘要： 目的探讨乳酸脱氢酶（LDH）对维吾尔族急性ST抬高型心肌梗死（STEMI）患者急性左心衰的临床价值。方法回顾性分析2020年1-12月新疆喀什地区第一人民医院332例维吾尔族STEMI患者,根据患者住院期间是否发生急性左心衰分为心衰组（n=174）和对照组（n=158）。比较两组患者的临床基本资料,同时应用logistic回归分析影响维吾尔族STEMI患者院内急性左心衰的危险因素。结果单因素分析可知,两组患者年龄、心率、LDH、D-二聚体、血清肌酐（Cr）、甘油三酯、糖尿病史、左心室射血分数、左室舒张末期内径差异有统计学意义（P<0.05）;多因素logistic回归分析显示年龄、心率、LDH、Cr和糖尿病史是维吾尔族STEMI患者急性左心衰的独立危险因素（P<0.05）。结论年龄、心率快、Cr升高、高水平LDH和糖尿病史是维吾尔族STEMI患者急性左心衰的独立危险因素,结合其他因素,LDH可用于评估心梗后急性左心衰风险。

关键词: 急性ST抬高型心肌梗死, 急性左心衰, 乳酸脱氢酶, 维吾尔族

刘佳璇, 龚志文, 张光武, 莫力懿, 张群英. 乳酸脱氢酶对评估维吾尔族急性ST段抬高型心肌梗死患者急性左心衰的临床价值[J]. 心血管病防治知识, 2021, 11(12): 21-24.

参考文献

[1] Lüscher TF.Risk factors for and management of heart failure[J]. Eur Heart J, 2015 ,36(34):2267-2269.
[2] Velagaleti RS, Pencina MJ, Murabito JM, et al.Long-term trends in the incidence of heart failure after myocardial infarction[J]. Circulation,2008,118: 2057-2062.
[3] Jensen J, Ma LP, Fu ML, et al.Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio[J].Clin Res Cardiol,2010,99(7):445-452.
[4] Vickery S, Price CP, John RI, et al.B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy[J]. Am J Kidney Dis, 2005, 46(4): 610-620.
[5] Li J, Li X, Wang Q, et al.China PEACE Collaborative Group. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data.[J].Lancet, 2015,385(9966):441-451.
[6] 2020心肌梗死后心力衰竭防治专家共识[J].中国循环杂志,2020,(12):1166-1180.
[7] Yamaguchi S, Abe M, Arakaki T, et al.Prognostic Value of Lactate Dehydrogenase for Mid-Term Mortality in Acute Decompensated Heart Failure: A?Comparison to Established Biomarkers and Brain Natriuretic Peptide[J]. Heart Lung Circ,2020,(9):1318-1327.
[8] Wu LW, Kao TW, Lin CM, et al.Examining the association between serum lactic dehydrogenase and all-cause mortality in patients with metabolic syndrome: a retrospective observational study[J]. BMJ Open,2016,6(5):11186.
[9] 王娜,左艳芳,李宗赢,等.急性心肌梗死行急诊PCI后发生射血分数保留性心力衰竭的危险因素及预后分析[J].中国循证心血管医学杂志,2020,12(9):1122-1124,1128.
[10] 沙沙. 急性ST段抬高心肌梗死患者合并心力衰竭的危险因素分析[J].心血管病防治知识(学术版),2014,(20): 96-97.
[11] Pek PP, Zheng H, Ho AFW, et al.Comparison of epidemiology, treatments and outcomes of ST segment elevation myocardial infarction between young and elderly patients[J]. Emerg Med J,2018,35(5):289-296.
[12] 张武宁,陈牧雷,杨新春,等.心肌细胞凋亡在老年性缺血再灌注后心力衰竭发生中的作用[J].中华老年心脑血管病杂志,2013,15(8):795-798.
[13] Meeusen JW, Lieske JC.Looking for a better creatinine[J]. Clin Chem,2014,60(8):1036-1039.
[14] 郭英. 急性ST段抬高心肌梗死患者合并心力衰竭的危险因素分析[J].中国实用医药,2017,12(5):70-71.
[15] 王洪旗,刘胜珍,庄晓赛,等.入院血糖水平对STEMI患者行急诊PCI术后心功能的影响[J].中国循证心血管医学杂志,2017,9(1):99-101.
[16] Mansour AA, Wanoose HL.Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance[J]. Oman Med J,2011,26(2):85-90.
[17] Bhatt DL, Szarek M, Steg PG, et al.Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure[J]. N Engl J Med,2021,384(2):117-128.
[18] Ghosh-Swaby OR, Goodman SG, Leiter LA, et al.Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials[J]. Lancet Diabetes Endocrinol,2020,8(5):418-435.
[19] Elsman P, Zijlstra F, Miedema K, et al.The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty[J]. Ann Clin Biochem, 2004,41(2):142-148.